Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
BioCryst Pharmaceuticals, Inc.
Type
Public (NASDAQ: BCRX)
Industry Healthcare
Founded 1986
Headquarters Durham, North Carolina, USA
Key people
Jon P. Stonehouse , President and Chief Executive Officer
Thomas Staab II, Chief Financial Officer
Products Biotechnology
Revenue IncreaseUS$26.3M (FY 2012)
Operating income
DecreaseUS$-33.9M (FY 2012)
Net income
DecreaseUS$-39.1M (FY 2012)
Total assets DecreaseUS$57.4M (FY 2012)
Total equity DecreaseUS$-0.4M (FY 2012)
Number of employees
37 (2013)
Website www.biocryst.com

BioCryst Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Durham, North Carolina. The company focuses on orphan & autoimmune diseases, and antivirals. The company's most advanced drug candidate is the antiviral Peramivir, which is approved in Japan, Korea and China. It was authorized by the FDA for emergency use in the treatment of patients hospitalized with influenza during the 2009-10 influenza A virus subtype H1N1 pandemic.

Investment goal date:
Dividends reinvested
BioCryst Pharmaceuticals, Inc. BCRX report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-02-23
--
--
Q3 2017
2017-11-07
--
--
Q2 2017
2017-08-07
-0.2100
-0.2100
Q1 2017
2017-05-04
-0.1900
-0.1900
Q4 2016
2017-02-27
-0.0600
-0.0600
Q3 2016
2016-11-07
-0.1600
-0.1600
Q2 2016
2016-08-04
-0.2200
-0.2200
Q1 2016
2016-05-05
-0.3100
-0.3100
Q4 2015
2016-02-23
-0.2500
-0.2500
Q3 2015
2015-11-05
-0.2000
-0.2000
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BAKER BROS. ADVISORS LP
11716784
BlackRock Fund Advisors
3401744
BlackRock Inc.
6014277
BlackRock Institutional Trust Company, N.A.
2079497
D. E. Shaw & Co., Inc.
3153628
DEERFIELD MANAGEMENT CO
3085236
FMR LLC
1456885
Ghost Tree Capital, LLC
1500000
JENNISON ASSOCIATES LLC
1844636
Longwood Capital Partners LLC
1245310
RA CAPITAL MANAGEMENT, LLC
3489795
RTW INVESTMENTS, LLC
3458120
STATE STREET CORP
2272104
Vanguard Group, Inc
5011763
venBio Select Advisor LLC
1603001
Major Shareholders
Name Relationship
Total Shares
Holding stocks
SANDERS CHARLES A
0.0200% (12971)
BCRX / BIOD / LPDX /
BAKER FELIX
0.2000% (145533)
LOWREY ROBERT S
0.0100% (9766)
BCRX /
LEE KENNETH B JR
0.0100% (10252)
ARLZ / BCRX / POZN /
INGRAM ROBERT ALEXANDER
0.0200% (11440)
STAAB THOMAS R II
0.2100% (149210)
BCRX /
BAKER BROS. ADVISORS LP
13.1300% (9418390)
Cohen Fred E
0.1700% (119410)
Hutson Nancy J
0.0500% (34167)
BCRX / CBST / ENDP /
Stonehouse Jon P
0.9000% (645418)
BCRX /
McCullough David
0.0300% (24124)
BCRX /
Sheridan William P
0.1200% (82916)
BCRX /
Babu Yarlagadda S
0.1500% (104706)
BCRX /
ABERCROMBIE GEORGE B
0.0100% (10000)
BCRX / OCRX / THRX / ZIOP /
Jensen Peder
0.0800% (60000)
ACOR / BCRX / FPRX /
Barnes Alane P
0.1100% (75497)
BCRX /
% ()